AEGEA Medical is a Menlo Park-based company that has developed an FDA-approved water vapor ablation system for the treatment of menorrhagia in premenopausal women. Their Adaptive Vapor Ablation technology delivers safe and effective endometrial ablation in a simple, office-based procedure that takes only minutes. AEGEA's vision is to expand safe and effective treatment options to more patients and provide physicians with the confidence and convenience necessary to perform office-based procedures, inspiring new approaches to women's healthcare. Since its founding in 2008, AEGEA Medical has been pioneering the application of its technology to deliver therapies that provide high-quality patient outcomes to a broader range of women.